Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (91-100 of 333) with videos related to

Pageof 34
Sort By:
Medicina (Kaunas, Lithuania)|May 27, 2023
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit TreatmentMichael Nagel, Ruben Westphal, Max Hilscher, et al.
Journal of Gastroenterology and Hepatology|August 18, 2025
Hepatic Inflammation and Liver Injury in a Model of Bacterial Infection Triggered Acute-on-Chronic Liver InjuryS C Karatayli, S N Weber, R A Hall, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Hepatology Communications|November 9, 2019
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolChristian Labenz, Jürgen H Prochaska, Yvonne Huber, et al.
United European Gastroenterology Journal|January 11, 2024
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetesMaurice Michel, Michelle Doll, Nastasia Albert, et al.
AIDS (London, England)|July 18, 2022
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIVMaurice Michel, Christian Labenz, Alisha Wahl, et al.
Journal of Clinical Medicine|October 14, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician PerspectiveWayne Eskridge, Donna R Cryer, Jörn M Schattenberg, et al.
Cell Death & Disease|May 31, 2022
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failureNadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Gut|December 11, 2020
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysisAlessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
European Journal of Internal Medicine|September 19, 2019
Health-related quality of life in patients with compensated and decompensated liver cirrhosisChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Pageof 34

Showing results (91-100 of 333) with videos related to

Sort By:
Pageof 34
Medicina (Kaunas, Lithuania)|May 27, 2023
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit TreatmentMichael Nagel, Ruben Westphal, Max Hilscher, et al.
Journal of Gastroenterology and Hepatology|August 18, 2025
Hepatic Inflammation and Liver Injury in a Model of Bacterial Infection Triggered Acute-on-Chronic Liver InjuryS C Karatayli, S N Weber, R A Hall, et al.
Scientific Reports|September 17, 2024
Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosisMaurice Michel, Jesús Funuyet-Salas, Michelle Doll, et al.
Hepatology Communications|November 9, 2019
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolChristian Labenz, Jürgen H Prochaska, Yvonne Huber, et al.
United European Gastroenterology Journal|January 11, 2024
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetesMaurice Michel, Michelle Doll, Nastasia Albert, et al.
AIDS (London, England)|July 18, 2022
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIVMaurice Michel, Christian Labenz, Alisha Wahl, et al.
Journal of Clinical Medicine|October 14, 2023
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician PerspectiveWayne Eskridge, Donna R Cryer, Jörn M Schattenberg, et al.
Cell Death & Disease|May 31, 2022
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failureNadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Gut|December 11, 2020
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysisAlessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
European Journal of Internal Medicine|September 19, 2019
Health-related quality of life in patients with compensated and decompensated liver cirrhosisChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Pageof 34